Atea has given a breakout after bottom formation, and now retesting the support. Long trade seems good. Sl: 25. With Good phase II interim result might have a good run
Disclaimer: The stock/index/currency discussed do not constitute Investment/trading advise and is merely an effort towards enhancing learning, knowledge and book keeping. Kindly do your own due...
I don’t usually put stocks that trade less than 2m shares/day on average on my watchlist but this chart is too sexy to pass up. I’ll be looking for a pullback to the annual pivot just below 30 and the monthly pivot at 29.41 as areas of Interest. The only real problem I have with this setup is that it already pushed into the weekly 20sma. Therefore it may find...
$AVIR continue its surge it share price, with a overall cumulative gain of +38.31% since it was last highlighted this month. The continuation of all time high breakout have successfully negated two series of Bearish Shooting Star reversal candlestick pattern that was printed on 14th and 15th January 2021 respectively. This rally have successfully place $AVIR at a...
$AVIR capped off the week’s market session with a considerable gain of +15.03%. This morning’s continuation all time high breakout have successfully negated the Bearish Shooting Star reversal candlestick pattern that was printed on 4th January 2021. The week’s rally also sums up an impressive cumulative gain of +77.36% since its IPO on 30th October 2020, just 10...
IPO intraday trading strategy idea
Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can...
It looks like a pattern of slight trend reversal has ended this last week, with MACD not yet beginning to converge for another downward cross. Movement within Bollinger Bands last week also looked good for bulls going into the week of 6/19. You could definitely see AVIR above .60 if it gets more than a dead cat bounce off of the .51
NASDAQ:AVIR AVIR is a therapuetical company that dropped 37% eighteen days ago due to failed drug trials. It has a gap to cover at 0.74 - 1.04. ADX just went down for the first time in 20 trading days indicating the downtrend is weakening. MACD just crossed over the signal line for the first time in 19 days and theyre significantly diverging. RSI is close to...
AVIR seems making a double bottom after the previous gap up. I'm looking for a potential harmonic pattern or a second test on the neckline level. A lower low invalidates this setup.
